Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Group Regulatory News (COST)

Share Price Information for Costain Group (COST)

Share Price is delayed by 15 minutes
Get Live Data
205.50    -4.50 (-2.14%)
Bid:
205.00
Ask:
206.50
Spread: 1.50 (0.732%)
Market Cap: £547.02m
COST Live PriceLast checked at - London Stock Exchange

Intraday Costain Group Share Chart

Scrip Dividend Reference Price

18 Sep 2025 14:00

RNS Number : 9239Z
Costain Group PLC
18 September 2025
 

 

 

Costain Group PLC (the 'Company')

18 September 2025

 

Scrip Dividend Reference Price

 

The Company announces that the Scrip Dividend Reference Price for the fully paid shares in the Company to be issued to shareholders who elect to receive the scrip dividend alternative for the interim dividend for the year ending 31 December 2025 is 127.28 pence per ordinary share of 1 pence each.

The Scrip Dividend Reference Price has been calculated as the average value of the middle market quotations for the Company's ordinary shares as derived from the Daily Official List of the London Stock Exchange for the five consecutive dealing days commencing on the ex-dividend date. The Company's ordinary shares were marked ex-dividend on 11 September 2025.

Further Information:

Shareholders wishing to receive the scrip dividend in respect of the interim dividend for the year ending 31 December 2025 and who have not already submitted a mandate form should return a mandate form to the Registrar, Equiniti, Share Dividend Team, Aspect House, Spencer Road, Lancing, West Sussex, BN99 6DA by 26 September 2025.

For more information regarding the scrip dividend including the terms, and to download the mandate form, see Costain scrip

If you have already completed a valid scrip dividend mandate form, it will remain valid until you cancel your election and you need not return any further documentation to receive this scrip dividend.

The interim dividend for the year ending 31 December 2025, including the scrip dividend, will be paid on 17 October 2025 (the dividend payment date), to the ordinary shareholders of the Company on the register at close of business on 12 September 2025 (the record date).

For further information, please contact Equiniti on +44 (0)371 384 2268*.

 

Enquiries

 

 

Investors and analysts

matt.jones@costain.com 

Matthew Jones, Costain

+44 (0) 7860 922 341

Financial media - Headland

costain@headlandconsultancy.com 

Andy Rivett-Carnac

+44 (0) 7968 997 365

Charlie Twigg

+44 (0) 7946 494 568

 

 

* Please use the country code when calling from outside the UK. Lines are open from 08:30 to 17:30 (UK time), Monday to Friday (excluding public holidays in England and Wales).

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVZZGMLMRGGKZM
Date   Source Headline
11th Jan 20167:00 amRNSConfirmation of Contract Award
7th Jan 201612:17 pmRNSHolding(s) in Company
6th Jan 20167:00 amRNSTrading Update
4th Jan 20168:55 amRNSBlocklisting Interim Review
24th Dec 201512:17 pmRNSDirector/PDMR Shareholding
22nd Dec 201511:46 amRNSHolding(s) in Company
22nd Dec 20159:13 amRNSHolding(s) in Company
17th Dec 20157:00 amRNSRe Contract
9th Dec 201511:22 amRNSHolding(s) in Company
1st Dec 20159:24 amRNSHolding(s) in Company
16th Nov 20157:00 amRNSRe: Directorate
11th Nov 20159:56 amRNSBlocklisting Interim Review
30th Oct 201510:01 amRNSTotal Voting Rights
29th Oct 20159:42 amRNSHolding(s) in Company
20th Oct 20151:03 pmRNS2015 Interim Dividend - Scrip Alternative
28th Sep 201511:09 amRNSDirector/PDMR Shareholding
25th Sep 201511:34 amRNSHolding(s) in Company
24th Sep 201510:35 amRNSScrip Dividend Reference Price
15th Sep 20152:45 pmRNSTransfer of Shares
14th Sep 201511:22 amRNSHolding(s) in Company
11th Sep 201510:18 amRNSBoard Change
11th Sep 201510:12 amRNSHolding(s) in Company
24th Aug 20157:06 amRNSRe Contract
20th Aug 20157:00 amRNSHalf Yearly Report
17th Aug 20157:00 amRNSAcquisition
28th Jul 20159:33 amRNSNED Appointment
22nd Jul 20157:00 amRNSRe Contract
22nd Jul 20157:00 amRNSCompletion of Reorganisation of JV in Spain
1st Jul 20159:58 amRNSBlocklisting Interim Review
1st Jul 20157:00 amRNSChanges to JV in Spain
25th Jun 20157:00 amRNSTrading Update
5th Jun 20157:00 amRNSBusiness Briefing
3rd Jun 20157:00 amRNSRe Contract
29th May 20159:17 amRNSTotal Voting Rights and Capital
19th May 201510:24 amRNSDividend - Scrip Alternative
12th May 201510:34 amRNSDirector/PDMR Shareholding
8th May 20154:23 pmRNSLTIP - Blocklisting Application - Correction
7th May 201511:11 amRNSLong Term Incentive Plan - Listing Application
6th May 201511:49 amRNSResult of AGM
6th May 20157:01 amRNSAnnual General Meeting and Financial Calendar
30th Apr 20158:59 amRNSTotal Voting Rights and Capital
23rd Apr 20152:33 pmRNSScrip Dividend Reference Price
8th Apr 201512:25 pmRNSDirector/PDMR Shareholding
31st Mar 201511:16 amRNSTotal Voting Rights
23rd Mar 20157:00 amRNSRe Contract
20th Mar 20157:00 amRNSNotice of AGM and Annual Report and Accounts
17th Mar 201510:18 amRNSHolding(s) in Company
10th Mar 201510:11 amRNSDirector/PDMR Shareholding
3rd Mar 20152:39 pmRNSDividend Declaration
3rd Mar 20157:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.